Susquehanna International Group
RXIIW

Susquehanna International Group’s RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 RXIIW Stock Holding History

Susquehanna International Group’s Portfolio RXIIW Stock Details RXIIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,216,855
Closed -$288K – 10723
2017
Q4 		$288K Sell
2,216,855
-3,400
-0.2% -$559 ﹤0.01% 7657
2017
Q3 		$375K Sell
2,220,255
-1,967
-0.1% -$378 ﹤0.01% 7029
2017
Q2 		$400K Hold
2,222,222
– – ﹤0.01% 7050
2017
Q1 		$489K Hold
2,222,222
– – ﹤0.01% 6531
2016
Q4 		$444K Buy
+2,222,222
New +$400K ﹤0.01% 7242

Other funds holding RXIIW

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Susquehanna International Group's RXIIW Position: Q1 2018 in Review

Susquehanna International Group sold out of RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 (RXIIW) in Q1 2018, closing a stake of 2,216,855 shares — an estimated $288K sold.

Susquehanna International Group first reported a position in RXIIW in Q4 2016 and held it in 5 quarters. The position peaked at $489K in Q1 2017. 4 funds tracked by Wall St. Rank hold RXIIW as of Q1 2018.

  • Susquehanna International Group reported no remaining RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 position as of Q1 2018 after selling out during the quarter.
  • Susquehanna International Group sold 2,216,855 RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 shares in Q1 2018, an estimated $288K.
  • Susquehanna International Group first reported a position in RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 in Q4 2016 and held it in 5 quarters.
  • Susquehanna International Group's RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 position peaked at $489K in Q1 2017.
  • 4 funds tracked by Wall St. Rank held RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 as of Q1 2018.

Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.